- £43.40m
- £46.56m
- $29.49m
- 48
- 20
- 81
- 47
REG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Final results for the year ended 31 December 2023
AnnouncementREG - Tissue Regenix Group - Notice of Results
AnnouncementRCS - Tissue Regenix Group - First EU shipment & new distributor agreements
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Trading update for 2023
AnnouncementREG - Tissue Regenix Group - 2023 LTIP Grant
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - HPRA approval & distribution agreement in Spain
AnnouncementREG - Tissue Regenix Group - Director/PDMR Shareholding
AnnouncementREG - AIM - AIM Notice - 06/09/2023
AnnouncementREG - Tissue Regenix Group - New sports medicine product launch
AnnouncementREG - Tissue Regenix Group - Interim results
AnnouncementREG - Tissue Regenix Group - Exercise of Options and Total Voting Rights
AnnouncementREG - Tissue Regenix Group - Notice of interim results
AnnouncementREG - Tissue Regenix Group - Half-Year Trading Update
AnnouncementREG - Tissue Regenix Group - Distribution agreement for OrthoPure® XT in the UK
AnnouncementREG - Tissue Regenix Group - Distribution agreement with Australian Allografts
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
Announcement